Table 1: Percentage of IgG Positive EBV Patients Between Patients Treated with anti-TNF Agents (Cases) and Controls

Treated with Biologic (Anti-TNF) Biologic Naive p-Value
n IgG EBV n IgG EBV
Entire Study Population 72 90% 50 98% 0.1
RA Only 53 91% 46 98% 0.2
AS Only 6 67% 0 - -
PsA Only 9 100% 3 100% -
Other Inflammatory Arthritis Only 4 100% 1 100% -

RA = rheumatoid arthritis, AS = ankylosing spondylitis, PsA = Psoriatic arthritis.